Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 1 - 20 of 217
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Mar 2023, 4:30 am by Lawrence Solum
Merrell Dow Pharmaceuticals, Inc., (1993), on the standards for expert testimony, with 24 departing states, United States v. [read post]
17 Jun 2022, 2:09 pm by admin
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), legal scholars, judges, and lawyers have struggled with the structure and validity of expert opinion on specific causation. [read post]
29 Jan 2022, 6:24 pm by Jon L. Gelman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993), Fed.Rules, Evid.Rules 104(a), 702. [read post]
5 Jan 2022, 4:33 am by Jon L. Gelman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993).Where does the universe of disability terminate? [read post]
17 Jun 2021, 12:29 pm by admin
As a result, so-called Daubert hearings began taking place in district courts around the country, in parallel with other centralized proceedings in MDL 926. [read post]
1 Oct 2020, 5:00 am by William Sinclair
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the Frye test was the predominant standard for the admissibility of scientific evidence in state and federal courts. [read post]
7 Sep 2020, 11:33 am by Stuart Kaplow
Merrell Dow Pharmaceuticals, Inc., the Supreme Court held that Federal Rule of Evidence superseded Frye’s general acceptance test. [read post]
29 Jun 2020, 12:41 pm by Jim Robinson
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993), and the testimony is helpful to the trier of fact to understand the evidence through specialized, scientific, or technical expertise. [read post]
13 May 2020, 2:03 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 592 n.10 (1993). [3]  Id., citing Bourjaily v. [read post]
11 May 2020, 1:09 am by Schachtman
That was the tradition that stood in active need of reform when Daubert was decided in 1993. [read post]
8 May 2020, 3:47 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [2]  Frye v. [read post]